Anti-Doping Policy for USGA Championships

The United States Golf Association, along with other leading golf organizations, has determined that it is in the best interest of the sport of golf to maintain the integrity of the game and the health and safety of all players. Accordingly, the USGA supports the efforts to develop and implement anti-doping programs. The USGA will honor, as it deems appropriate, the findings, final penalties and sanctions rendered by other leading golf organizations for anti-doping violations, taking due account of the seriousness and timing of the violations. All participants in USGA championships are encouraged to review the anti-doping programs of their respective golf organizations as testing may occur within the time periods in which they are participating in a USGA championship; all participants are also encouraged to review the Conditions of Competition of applicable USGA championships.

The USGA will incorporate and adopt the PGA Tour’s Anti-Doping Program for the U.S. Open Championship for all participants in the championship proper. The USGA will incorporate and adopt the LPGA’s Anti-Doping Protocol for the U.S. Women’s Open Championship for all participants in the championship proper.

The USGA will incorporate and adopt the International Golf Federation's Anti-Doping Policy for the U.S. Amateur Championship and U.S. Women's Amateur Championship for all participants in the championship proper.

Drug Testing Processes

U.S. Open:

Compliance with the drug testing program is a condition of entry to the championship. Any player who refuses to participate in the testing process may be disqualified and subject to sanctions.

Drug testing at the U.S. Open will be administered in cooperation with the PGA Tour’s Anti-Doping Program.

  • The list of Prohibited Substances and Methods is contained in Section 5 of the Manual 
  • The Therapeutic Use Exemption (TUE) process is addressed in Section 6 of the Manual 
  • TUE requests must be submitted to the PGA TOUR no later than five (5) days after having been notified that you have been accepted into sectional qualifying, or within ten (10) days of having received an exemption to play in the U.S.Open Championship.

Questions regarding the Anti-Doping Program Manual and TUE process should be directed to Andy Levinson, Executive Director of the PGA Tour’s Anti-Doping Program at (904) 280-2487 or andylevinson@pgatour.com.

General questions regarding the USGA’s Anti-Doping Policy can be directed to the USGA’s Anti-Doping Program Administrator at (908) 326-1897.

*For the avoidance of doubt, the application of this Policy is for all participants in the championship proper, regardless of whether or not you are a member of the PGA Tour.

U.S. Women's Open:

Compliance with the drug testing program is a condition of entry to the Championship. Any player who refuses to participate in the testing process may be disqualified and subject to sanctions.

Drug testing at the U.S. Women's Open will be administered in cooperation with the LPGA's Anti-Doping Program Protocol

  • The Program Description, Anti-Doping Protocol, Prohibited Substance List, and examples of Permitted Medications List, Frequently Asked Questions document, and Therapeutic Use Exemption (TUE) Application And Procedures are all separately identified. 
  • All TUE requests should be submitted in accordance with the LPGA Procedures and submitted to the LPGA no later than five (5) days after having been notified that you have been accepted into sectional qualifying, or within ten (10) days of having received an exemption to play in the U.S. Women’s Open Championship.  

Questions regarding the Anti-Doping Protocol or TUE Process should be directed to the LPGA’s Assistant General Counsel at (386) 274-6284 or Josh.Kane@lpga.com. Questions regarding particular substances, including dietary supplements and vitamins should be addressed to the LPGA Drug Reference Hotline at 1-877-285-1436 or at drugtesting@lpga.com.

General questions regarding the USGA’s Anti-Doping Policy can be directed to the USGA’s Anti-Doping Program Administrator at (908) 326-1897.

*For the avoidance of doubt, the application of this Policy is for all participants in the championship proper, regardless of whether or not you are a member of the LPGA.

U.S. Amateur and U.S. Women's Amateur:

Compliance with the drug testing program is a condition of entry to the championship. Any player who refuses to participate in the testing process may be disqualified and subject to sanctions.

Drug testing at the U.S. Amateur Championship and U.S. Women’s Amateur Championship will be administered in cooperation with the International Golf Federation’s (IGF) Anti Doping Program. The Program Manual can be found on www.igfgolf.org. The information can also be found on the Drug Free Sport (DFS) website on www.drugfreesport.com.

  1. Once on the DFS website, click the REC LOGIN icon in the upper right hand corner of the page
  2. Using the dropdown box, choose USGA as the organization and log into the site using the password usgarec
  3. Click Drug Program Information at the top of the page
  4. Click on the IGF Anti-Doping Policy
  5. Click on the current list of Prohibited Substances and Methods (also found at www.wada-ama.org)the Summary of Major Modifications and Explanatory Notes for 2015 can be found here
  6. Click Here for the Therapeutic Use Exemption(TUE) form. Do not use the form from the IGF Policy manual/website
  • A TUE request must be received by the USGA’s Medical Advisor no later than five (5) days after having been notified that you have been accepted into sectional qualifying, or within ten (10) days of having received an exemption to play in the U.S. Amateur Championship or U.S. Women’s Amateur Championship. Submit the USGA’s TUE form and any related questions and documentation directly to the USGA Medical Advisor, Thomas G. Hospel, MD, MBG at thospel@yahoo.com. Specific questions about medications, substances, methods, dietary supplements or vitamins, or to obtain a TUE should be sent directly to Dr. Thomas Hospel at thospel@yahoo.com or by phone (614) 537-3000.

Questions about dietary supplements and banned substances may also be sent to the National Center for Drug Free Sport at www.drugfreesport.com by 1) following the steps outlined above for the DFS website or 2) sent to DFS by facsimile at 816-285-5068 or 3) by calling the REC hotline 1-877-285-1434.

General questions regarding the USGA’s Anti-Doping Policy can be directed to the USGA’s Anti-Doping Program Administrator at (908) 326-1897.

More from the USGA